NO841594L - Fremgangsmaate for fremstilling av terapeutisk aktive triazin-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive triazin-derivater.

Info

Publication number
NO841594L
NO841594L NO841594A NO841594A NO841594L NO 841594 L NO841594 L NO 841594L NO 841594 A NO841594 A NO 841594A NO 841594 A NO841594 A NO 841594A NO 841594 L NO841594 L NO 841594L
Authority
NO
Norway
Prior art keywords
compound
salt
general formula
defined above
methyl
Prior art date
Application number
NO841594A
Other languages
English (en)
Norwegian (no)
Inventor
Tsutomu Teraji
Youichi Shiokawa
Kazuo Okumura
Yoshinari Sato
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO841594L publication Critical patent/NO841594L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Color Electrophotography (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO841594A 1983-04-22 1984-04-18 Fremgangsmaate for fremstilling av terapeutisk aktive triazin-derivater. NO841594L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58072013A JPS59196874A (ja) 1983-04-22 1983-04-22 トリアジン誘導体

Publications (1)

Publication Number Publication Date
NO841594L true NO841594L (no) 1984-10-23

Family

ID=13477098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841594A NO841594L (no) 1983-04-22 1984-04-18 Fremgangsmaate for fremstilling av terapeutisk aktive triazin-derivater.

Country Status (15)

Country Link
US (1) US4618610A (de)
EP (1) EP0123254B1 (de)
JP (1) JPS59196874A (de)
KR (1) KR840008341A (de)
AT (1) ATE35259T1 (de)
AU (1) AU2701584A (de)
DE (1) DE3472255D1 (de)
DK (1) DK201684A (de)
ES (3) ES8507517A1 (de)
FI (1) FI841527A7 (de)
GR (1) GR81788B (de)
HU (1) HU192010B (de)
NO (1) NO841594L (de)
PH (1) PH20020A (de)
ZA (1) ZA842700B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
DE19929781A1 (de) * 1999-06-29 2001-01-04 Bayer Ag N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
MX373178B (es) * 2007-04-03 2020-04-22 Fmc Corp Star Fungicidas de benceno sustituido.
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
EP3661917B1 (de) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-on-derivate als pde3a and pde3b inhibitoren zur behandlung von krebs
AU2020215088A1 (en) 2019-02-01 2021-07-22 Bayer Aktiengesellschaft 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052442B1 (de) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclische Derivate
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives

Also Published As

Publication number Publication date
DK201684D0 (da) 1984-04-18
DE3472255D1 (en) 1988-07-28
PH20020A (en) 1986-09-01
ATE35259T1 (de) 1988-07-15
HU192010B (en) 1987-04-28
FI841527A0 (fi) 1984-04-17
GR81788B (de) 1984-12-12
ES531793A0 (es) 1985-09-01
FI841527A7 (fi) 1984-10-23
EP0123254B1 (de) 1988-06-22
US4618610A (en) 1986-10-21
HUT34173A (en) 1985-02-28
KR840008341A (ko) 1984-12-14
AU2701584A (en) 1984-10-25
ES539653A0 (es) 1985-11-16
JPS59196874A (ja) 1984-11-08
ES8507517A1 (es) 1985-09-01
JPH0235752B2 (de) 1990-08-13
EP0123254A1 (de) 1984-10-31
DK201684A (da) 1984-10-23
ES8606305A1 (es) 1986-04-16
ES539654A0 (es) 1986-04-16
ZA842700B (en) 1984-11-28
ES8602706A1 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
Balsiger et al. Synthesis of Potential Anticancer Agents. XXV. Preparation of 6-Alkoxy-2-aminopurines2
AU2004278276B2 (en) New 2-substituted, 4-amino-thiazolo(4,5-d) pyrimidines, useful as chemokine receptor antagonists, esp. CX3CR1
HUP0203477A2 (hu) Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaik
WO2010092966A1 (ja) 新規トリアジン誘導体およびそれを含有する医薬組成物
NO881531L (no) Acylderivater.
US5138057A (en) Chemical process for the preparation of purine derivatives
BR112014032229B1 (pt) método para produzir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3- il]piridina-2-carbonitrila
NO841594L (no) Fremgangsmaate for fremstilling av terapeutisk aktive triazin-derivater.
US4616015A (en) Triazine derivatives, and pharmaceutical compositions comprising the same
Mosselhi et al. Synthesis and Tautomeric Structure of 7-Arylhydrazono-7H-[1, 2, 4] Triazolo [3, 4-b][1, 3, 4] Thiadiazines
MXPA03010985A (es) Derivados d eimidazotriazinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias.
EP0041359B1 (de) Verfahren zur Herstellung von heterozyklylalkylguanidinen, Zwischenprodukte und deren Herstellung
Al-Salahi et al. Synthesis of novel 2-phenoxybenzo [g][1, 2, 4] triazolo [1, 5-a] quinazoline and its derivatives starting with diphenyl-N-cyanoimidocarbonate
Reiter et al. On triazoles. VIII The reaction of 5‐amino‐1, 2, 4‐triazoles with ethyl 2‐cyano‐3‐ethoxyacrylate and 2‐cyano‐3‐ethoxyacrylonitrile
Kaji et al. 3‐Alkylthio and 3‐aminopyrazolo [3, 4‐D] pyridazines. Ring contraction of pyridazino [4, 5‐e][1, 3, 4] thiadiazines via extrusion of sulfur
Hung et al. Central Nervous System Active Compounds. XV. 2-Arylisoxazol-5 (2 H)-ones
Takei et al. A new synthetic method for some pyrazolo [4, 3-d] pyrimidines.
Kryl’skii et al. Arylbiguanides in heterocyclization reactions
EP1065202B1 (de) 6-(alpha-fluoroalkyl)-4-pyrimidone und verfahren zu ihrer herstellung
Solovyev et al. Synthesis and oxidative aromatization of 5-acetyl-2-cyanoimino-6-methyl-4-phenyl-1, 2, 3, 4-tetrahydropyrimidine with manganese dioxide
Mekuskiene et al. 5-(4, 6-Diphenyl-2-pyrimidinyl)-1, 3, 4-oxa (thia) diazoles and 1, 2, 4-triazoles
Wamhoff et al. Efficient Synthesis of Fused Isothiazole C-Nucleosides. 2. Synthesis of 8-Aza-7, 9-deaza-7-thiaguanosine and 8-Aza-7, 9-deaza-7-thiaadenosine
McFadden et al. Synthesis of Pyrazoles and Pyrazolo [1, 5-a] pyrimidines From 3-Arylsulfonylaminoacrylates
Čmelík et al. Syntheses and Structure Study on 3, 3aλ 4, 4-Trithia-1-azapentalenes and Their 3-Oxa Analogues
Brzozowski et al. Syntheses of potassium 1, 1‐dioxopyrido [4, 3‐e]‐1, 4, 2‐dithiazine‐3‐thiolate and its application to the synthesis of novel sulfonamides with potential biological activity